These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 31084193)

  • 1. IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.
    Xing Z; Zhang H; She D; Lin Y; Zhou X; Zeng Z; Cao D
    Acta Radiol; 2019 Dec; 60(12):1663-1672. PubMed ID: 31084193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Histogram Features on Arterial Spin Labeling Perfusion Magnetic Resonance Imaging in Identifying Isocitrate Dehydrogenase Genotypes and Glioma Malignancies.
    Su C; Peng C; Sun Y; Damen FC; Jiang R; Xie C; Cai K
    Turk Neurosurg; 2024; 34(4):578-587. PubMed ID: 38874235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma distribution model of diffusion MRI for evaluating the isocitrate dehydrogenase mutation status of glioblastomas.
    Takase H; Togao O; Kikuchi K; Hata N; Hatae R; Chikui T; Tokumori K; Kami Y; Kuga D; Sangatsuda Y; Mizoguchi M; Hiwatashi A; Ishigami K
    Br J Radiol; 2022 May; 95(1133):20210392. PubMed ID: 35138915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating IDH-mutant astrocytomas and 1p19q-codeleted oligodendrogliomas using DSC-PWI: high performance through cerebral blood volume and percentage of signal recovery percentiles.
    Pons-Escoda A; Garcia-Ruiz A; Naval-Baudin P; Martinez-Zalacain I; Castell J; Camins A; Vidal N; Bruna J; Cos M; Perez-Lopez R; Oleaga L; Warnert E; Smits M; Majos C
    Eur Radiol; 2024 Aug; 34(8):5320-5330. PubMed ID: 38282078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generative adversarial network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate dehydrogenase mutant type.
    Park JE; Eun D; Kim HS; Lee DH; Jang RW; Kim N
    Sci Rep; 2021 May; 11(1):9912. PubMed ID: 33972663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of pseudoprogression in post-treatment glioblastoma using dynamic susceptibility contrast-derived oxygenation and microvascular transit time heterogeneity measures.
    Park JE; Kim HS; Kim N; Borra R; Mouridsen K; Hansen MB; Kim YH; Hong CK; Kim JH
    Eur Radiol; 2024 May; 34(5):3061-3073. PubMed ID: 37848773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined 3 Tesla MRI Biomarkers Improve the Differentiation between Benign vs Malignant Single Ring Enhancing Brain Masses.
    Salice S; Esposito R; Ciavardelli D; Delli Pizzi S; di Bastiano R; Tartaro A
    PLoS One; 2016; 11(7):e0159047. PubMed ID: 27410226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype.
    Dono A; Torres J; Nunez L; Arevalo O; Rodriguez-Quinteros JC; Riascos RF; Kamali A; Tandon N; Ballester LY; Esquenazi Y
    J Neurooncol; 2024 Mar; 167(1):99-109. PubMed ID: 38351343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive assessment of Ki-67 labeling index in glioma patients based on multi-parameters derived from advanced MR imaging.
    Hu Y; Zhang K
    Front Oncol; 2024; 14():1362990. PubMed ID: 38826787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas.
    Sim HW; Lorrey S; Khasraw M
    Curr Neurol Neurosci Rep; 2023 Jun; 23(6):263-276. PubMed ID: 37154886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI characteristics of H3 G34-mutant diffuse hemispheric gliomas and possible differentiation from IDH-wild-type glioblastomas in adolescents and young adults.
    Shao H; Gong J; Su X; Chen N; Li S; Yang X; Zhang S; Huang Z; Hu W; Gong Q; Liu Y; Yue Q
    J Neurosurg Pediatr; 2024 Mar; 33(3):236-244. PubMed ID: 38157540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between prognosis and temporal muscle thickness in 102 patients with glioblastoma.
    Tang J; Dong Z; Yang L; Yang P; Zhao W; Deng L; Xue J; Cui Y; Li Q; Tang L; Sheng J; Zhang Y; Zhang H; Chen T; Dong B; Lv X
    Sci Rep; 2024 Jun; 14(1):13958. PubMed ID: 38886495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cell ferroptosis influences IDH wild-type glioblastoma growth in recurrent glioblastoma multiforme patients.
    Liang B; Ding X; Yang S; Feng E
    Braz J Med Biol Res; 2024; 57():e13961. PubMed ID: 38985083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the Editor. Prediction model of IDH wild-type glioblastoma.
    Yu ZY; Chung MH; Wang PW; Wu YC; Liao HC; Hueng DY
    J Neurosurg; 2022 Jun; 137(4):1200. PubMed ID: 36183188
    [No Abstract]   [Full Text] [Related]  

  • 15. Unlocking Bevacizumab's Potential: rCBV
    Álvarez-Torres MDM; Balaña C; Fuster-García E; Puig J; García-Gómez JM
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels.
    Ho WM; Chen CY; Chiang TW; Chuang TJ
    Acta Neuropathol Commun; 2024 Jul; 12(1):119. PubMed ID: 39030655
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.
    Yang X; Lin Y; Xing Z; She D; Su Y; Cao D
    Acta Radiol; 2021 Dec; 62(12):1657-1665. PubMed ID: 33222488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive Determination of
    Bhandari AP; Liong R; Koppen J; Murthy SV; Lasocki A
    AJNR Am J Neuroradiol; 2021 Jan; 42(1):94-101. PubMed ID: 33243896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DSC-PWI presurgical differentiation of grade 4 astrocytoma and glioblastoma in young adults: rCBV percentile analysis across enhancing and non-enhancing regions.
    Pons-Escoda A; Naval-Baudin P; Viveros M; Flores-Casaperalta S; Martinez-Zalacaín I; Plans G; Vidal N; Cos M; Majos C
    Neuroradiology; 2024 Aug; 66(8):1267-1277. PubMed ID: 38834877
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.